Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 90, Issue 1, 2010, Pages 95-99

  Chen, Xiao Min ^a   Zhang, Yan ^a   Shen, Xing Ping ^a   Huang, Qun ^a   Ma, Hong ^a   Huang, Yang Ling ^a   Zhang, Wen Qiang ^a   Wu, Hao Jie ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Glucose fluctuations; Intima media thickness of carotid; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AGING; ATHEROSCLEROSIS; BLOOD GLUCOSE; CAROTID ARTERIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TUNICA INTIMA; TUNICA MEDIA;

EID: 77956188536     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.05.004     Document Type: Article

References (21)

1. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
2. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001, 161:397-405. DECODE Study Group.
3. Metzger M., Leibovitz G., Wainstein J., Glaser B., Razr Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002, 25:1185-1191.
4. klonoff D.C. Continuous glucose monitoring roadmap for 21st century therapy. Diabetes Care 2005, 28:1231-1239.
5. Garg S., Zisser H., Schwartz S., Railey T., Kaplan R., Ellis S., et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trail. Diabetes Care 2006, 29(1):44-50.
6. McDonnell C.M., Donath S.M., Vidmar S.I., Werther G.A., Cameron F.J. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005, 7:253-263.
7. Monnier L., Colette C., Boegner C., Pham T.C., Lapinski H., Boniface H. Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom?. Diabetes Metab 2007, 33:247-255.
8. Service F.J., Molnar G.D., Rosevear J.W., Ackerman E., Gatewood L.C., Taylor W.F. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970, 19:644-655.
9. Crouse J.R., Furberg C.D., Espeland M.A., Riley W.A. B-mode ultrasound: a noninvasive method for assessing atherosclerosis. Cardiovascular Medicine 2007, 1783-1791. Springer Press, New York. 3rd ed. J.T. Willerson (Ed.).
10. Minamikawa J., Yamauchi M., Tanaka S., Koshiyama H. Carotid arterial intimal-medial thickening and plaque formation in NIDDM. Diabetes Care 1998, 21:323-324.
11. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
12. Mazze R.S., Strock E., Borgman S., Wesley D., Stout P., Racchini J. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time?. Diabetes Techonol Ther 2009, 11:11-18.
13. Sachedina N., Pickup J.C. Performance assessment of the medtronic-minimed continuous glucose monitoring system and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med 2003, 20:1012-1015.
14. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ 2000, 321:405-412.
15. Coutinho M., Gerstein H.C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999, 22:233-240.
16. Wang T.J., Nam B.H., D'Agostino R.B., Wolf P.A., Lloyd-Jones D.M., MacRae C.A., et al. Carotid intima-media thickness is associated with premature parental coronary heart disease: The Framingham Heart Study. Circulation 2003, 108:572-576.
17. Mita T., Otsuka A., Azuma K., Uchida T., Ogihara T., Fujitani Y., et al. Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2007, 358:679-685.
18. Suwa T., Ohta A., Matsui T., Koganei R., Kato H., Kawata T., et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J 2009, 19. (in press).
19. Quagliaro L., Piconi L., Assaloni R., Martinelli L., Motz E., Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003, 52:2795-2804.
20. Wallenfeldt K., Hulthe J., Fagerberg B. The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med 2005, 258:28-37.
21. Monnier L., Colette C., Dunseath G.J., Owens D.R. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007, 30:263-269.